NeoGenomics Laboratories

NeoGenomics Laboratories Our tagline: Answers are in our DNA™
Our vision: A world where every cancer treatment decision is as personal as the patient.

NeoGenomics Laboratories is a premier cancer diagnostics and pharma services company dedicated to saving lives by improving patient care. NeoGenomics serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. At NeoGenomics, we team up with our clients to solve the challenges of making precise diagnoses, a

id in bringing new therapies to market, and finding the unique hallmarks of each patient’s disease that point the way to proper treatment.

We just wrapped up at , and 𝐭𝐡𝐚𝐧𝐤 𝐲𝐨𝐮. We connected with so many people and discussed how we can work together to advan...
06/02/2026

We just wrapped up at , and 𝐭𝐡𝐚𝐧𝐤 𝐲𝐨𝐮. We connected with so many people and discussed how we can work together to advance personalized cancer care across the care continuum. If we didn’t get a chance to meet, or you’d like to continue the discussion, we’d love to connect: mailchi.mp/neogenomics/asco2026.

The PD-L1 22c3 FDA for Ovarian Carcinoma (neogenomics.com/providers/test/APH-PDLO-01AX/pd-l1-22c3-fda-for-ovarian-carcin...
06/01/2026

The PD-L1 22c3 FDA for Ovarian Carcinoma (neogenomics.com/providers/test/APH-PDLO-01AX/pd-l1-22c3-fda-for-ovarian-carcinoma) seamlessly integrates into your existing molecular diagnostic workflow to provide comprehensive patient profiling through our PanTracer™ Portfolio and NeoTYPE® Ovarian assays.

Day 1 of the 2026 ASCO® Annual Meeting is underway! Visit us at booth #32130, or plan ahead by booking a meeting here: ...
05/30/2026

Day 1 of the 2026 ASCO® Annual Meeting is underway! Visit us at booth #32130, or plan ahead by booking a meeting here: mailchi.mp/neogenomics/asco2026.

We have a lot to share with you during :

🔬 Clinical, pharma, and data solutions
💡 Multimodal testing, emerging biomarkers solutions
📊 Real-world and clinicogenomic insights
▶️ An interactive video experience that highlights how supports precision oncology across clinical care, therapeutic development, and data solutions.

We’re excited to connect. See you on the show floor!

It’s Day 1 at the 2026 ASCO® Annual Meeting! Walk over to our booth at #32130, or plan ahead by booking a meeting here:...
05/30/2026

It’s Day 1 at the 2026 ASCO® Annual Meeting! Walk over to our booth at #32130, or plan ahead by booking a meeting here: mailchi.mp/neogenomics/asco2026.

We have a lot to share with you during :
🔬 Clinical, pharma, and data solutions
💡 Multimodal testing, emerging biomarkers solutions
📊 Real-world and clinicogenomic insights
▶️ An interactive video experience that highlights how supports precision oncology across clinical care, therapeutic development, and data solutions.

We’re excited to connect. See you on the show floor!

During , step into an interactive journey through the cancer care continuum and see how comprehensive clinical solution...
05/29/2026

During , step into an interactive journey through the cancer care continuum and see how comprehensive clinical solutions, therapeutic development support, and data-driven insights are shaping more informed, individualized decisions at every stage.

Bookmark this post, or visit us online to request a meeting here: mailchi.mp/neogenomics/asco2026

Our latest research will be featured online during the 2026 ASCO® Annual Meeting. We’re excited to share:• Concordance o...
05/29/2026

Our latest research will be featured online during the 2026 ASCO® Annual Meeting. We’re excited to share:
• Concordance of liquid biopsy and tissue CGP for identification of guideline-recommended actionable variants.
• Real-world evidence for comprehensive genomic profiling in myeloid malignancies: Changes in detection and clinical impact.
• Real-world concordance between actionable mutations and targeted therapy in acute myeloid leukemia (AML).
• Exploration of tumor-informed RaDaR ST ctDNA detection and dynamics in a real-world cohort of colorectal cancer patients from the MD Anderson Cancer Center.
• Clinical actionability and molecular landscapes of fusion-driven sarcomas: A multi-modal integration analysis of comprehensive genomic profiling, targeted RNA-sequencing, and PD-L1 expression.

View these abstracts online and connect with us to discuss the clinical implications and opportunities to advance precision oncology: https://mailchi.mp/neogenomics/asco2026.

Register for this upcoming webinar: Liquid Biopsy: Advancing Precision Care in Oncology 🔗 engagez.net/neowebinar4 =lobb...
05/28/2026

Register for this upcoming webinar: Liquid Biopsy: Advancing Precision Care in Oncology 🔗 engagez.net/neowebinar4 =lobby&lct=entrance.

Don’t miss this upcoming webinar exploring how a minimally invasive approach can complement tissue testing and improve patient outcomes through faster, more personalized treatment decisions.

Join the webinar! Liquid Biopsy: Advancing Precision Care in Oncology. Register online: engagez.net/neowebinar4 =lobby&l...
05/28/2026

Join the webinar! Liquid Biopsy: Advancing Precision Care in Oncology. Register online: engagez.net/neowebinar4 =lobby&lct=entrance.

Don’t miss this upcoming webinar exploring how a minimally invasive approach can complement tissue testing and improve patient outcomes through faster, more personalized treatment decisions.

We’re showcasing our latest research at the 2026 ASCO® Annual Meeting on June 1st from 9 AM – 12 PM:• From infancy to yo...
05/28/2026

We’re showcasing our latest research at the 2026 ASCO® Annual Meeting on June 1st from 9 AM – 12 PM:
• From infancy to young adulthood: Exploring the divergent genomic mechanisms that drive AML | Poster Board: 337
• Bridging the Gap Between Clinical Utility and Coverage: Real-World Impact of Unreimbursed NGS Testing | Poster Board: 177

Bookmark these details and contact us to discuss our findings and their implications for clinical care: https://mailchi.mp/neogenomics/asco2026.

Your therapeutic development journey? We can support that. Book a meeting with us during the 2026 ASCO® Annual Meeting ...
05/28/2026

Your therapeutic development journey? We can support that.
Book a meeting with us during the 2026 ASCO® Annual Meeting to learn more: mailchi.mp/neogenomics/asco2026.

Let’s connect at to discuss how we can help advance your pipeline from discovery through development with:
• Emerging biomarkers solutions
• AI-driven spatial biology solutions, including Paletrra, and multi-omic insights
• Molecular residual disease (MRD) testing across hematologic and solid tumors to inform clinical trials
• Actionable clinicogenomic and real-world insights

Address

9490 NeoGenomics Way
Fort Myers, FL
33912

Website

Alerts

Be the first to know and let us send you an email when NeoGenomics Laboratories posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to NeoGenomics Laboratories:

Shortcuts

Share

Category